Literature DB >> 17069590

Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution.

S Natsugoe1, H Okumura, M Matsumoto, Y Uchikado, T Setoyama, N Yokomakura, S Ishigami, T Owaki, T Aikou.   

Abstract

The purpose of the present study was to compare the clinical results between preoperative chemoradiotherapy followed by surgery (CRT group) and surgery alone (Surgery group) by a randomized controlled study. Twenty-two patients were assigned to the CRT group and 23 to the Surgery group. A total radiation dose of 40 Gy was applied and in the same period, intravenous chemotherapy was performed using cisplatin (7 mg over 2 h) and 5-fluorouracil (5-FU; 350 mg over 24 h). Surgical treatment was performed in 20 patients in the CRT group except for two patients with bone metastasis after CRT. According to histological effects of primary tumors, the number of patient with Grades 1, 2 and 3 was 11, 7 and 3, respectively. Frequency of lymphatic and venous invasion was significantly lower in the CRT group than in the Surgery group. The 5-year survival rate was 57% in the CRT group and 41% in the Surgery group (P = 0.58). According to the histological effect in the CRT group, 5-year survival was 30% for Grade 1, 83% for Grade 2 and 100% for Grade 3 (P = 0.0069). This randomized trial did not demonstrate a statistically significant survival difference between the CRT group and the Surgery group.

Entities:  

Mesh:

Year:  2006        PMID: 17069590     DOI: 10.1111/j.1442-2050.2006.00615.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  39 in total

1.  Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: a meta-analysis.

Authors:  Dong-Bin Wang; Xun Zhang; Hong-Li Han; Yi-Jun Xu; Da-Qiang Sun; Zhen-Liang Shi
Journal:  Dig Dis Sci       Date:  2012-06-14       Impact factor: 3.199

2.  Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu Feng Cao; Bin Zhu; Lv Ji; Lei Tao; Dong Dong Wang
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 3.  Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Hiroshi Saeki; Yuichiro Nakashima; Yoko Zaitsu; Yasuo Tsuda; Yuta Kasagi; Koji Ando; Yu Imamura; Kippei Ohgaki; Shuhei Ito; Yasue Kimura; Akinori Egashira; Eiji Oki; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2015-03-05       Impact factor: 2.549

Review 4.  Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy.

Authors:  Hiroshi Okumura; Yasuto Uchikado; Tetsuro Setoyama; Masataka Matsumoto; Tetsuhiro Owaki; Sumiya Ishigami; Shoji Natsugoe
Journal:  Surg Today       Date:  2013-04-19       Impact factor: 2.549

Review 5.  Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.

Authors:  Branislav Bystricky; Alicia F C Okines; David Cunningham
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

6.  Traditional and cumulative meta-analysis: Chemoradiotherapy followed by surgery versus surgery alone for resectable esophageal carcinoma.

Authors:  Haiming Feng; Ye Zhao; Tao Jing; Jianxing Ma; Yinglu Zhao; Jianhua Zhang; Cheng Wang; Bin Li
Journal:  Mol Clin Oncol       Date:  2017-12-12

7.  Meta-Analysis for the Therapeutic Effect of Neoadjuvant Therapy in Resectable Esophageal Cancer.

Authors:  Yusen Zhu; Min Liu; Xiaojing Yun; Dongmei Wang; Yuhuan Bai; Guizhi Zhang; Bei Ji; Changchun Jing
Journal:  Pathol Oncol Res       Date:  2016-12-24       Impact factor: 3.201

8.  Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis.

Authors:  Hai-Lin Jin; Hong Zhu; Ting-Sheng Ling; Hong-Jie Zhang; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

9.  High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.

Authors:  Meysan Hurmuzlu; Kjell Øvrebø; Odd R Monge; Rune Smaaland; Tore Wentzel-Larsen; Asgaut Viste
Journal:  World J Surg Oncol       Date:  2010-06-01       Impact factor: 2.754

Review 10.  Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.

Authors:  Jin Lv; Xiu-Feng Cao; Bin Zhu; Lv Ji; Lei Tao; Dong-Dong Wang
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.